Coenurosis (Gid Disease, Staggers, Coenurus cerebralis Infection)

Coenurosis, also known as gid disease or staggers, is a parasitic infection of the central nervous system (CNS) of sheep and goats caused by the larval stage (metacestode) of the tapeworm Taenia multiceps. The larval stage, Coenurus cerebralis, forms a fluid-filled cyst (coenurus) typically in the brain or spinal cord, leading to progressive neurological signs. The disease is of significant economic importance in sheep-rearing regions worldwide, particularly where dogs (the definitive host) have access to infected carcasses. In goats, the disease is less common but can occur, often with a more acute course. The condition is classified as a parasitic encephalomyelitis and is a major differential for other neurological diseases of small ruminants, including listeriosis, polioencephalomalacia, and pregnancy toxemia. The disease is zoonotic in rare cases, but human infection is extremely uncommon. Control relies on breaking the life cycle by preventing dogs from consuming infected offal, regular deworming of dogs, and proper carcass disposal.

The causative agent is the metacestode stage of Taenia multiceps, a cestode parasite belonging to the family Taeniidae. Adult tapeworms reside in the small intestine of canids, primarily domestic dogs, but also foxes, wolves, and other wild canids. Gravid proglottids are shed in the feces of the definitive host, releasing eggs that are highly resistant to environmental conditions. Sheep and goats become infected by ingesting eggs from contaminated pasture, feed, or water. After ingestion, the oncosphere (hexacanth embryo) is liberated in the small intestine, penetrates the intestinal wall, and enters the bloodstream. It then migrates to the CNS, where it develops into a Coenurus cerebralis cyst over a period of 2 to 8 months. The cyst is fluid-filled and contains multiple protoscolices (invaginated scoleces) attached to the inner wall. The presence of the cyst causes space-occupying lesions, inflammation, and necrosis in the brain tissue. The life cycle is completed when a dog consumes the brain or spinal cord of an infected sheep or goat, releasing protoscolices that develop into adult tapeworms in the dog's intestine. The prepatent period in dogs is approximately 6 to 8 weeks.

Coenurosis is distributed worldwide, with higher prevalence in regions where sheep farming is extensive and where dogs are used for herding or have access to raw sheep carcasses. In the United Kingdom, the disease is endemic in Wales and parts of Scotland, with a reported incidence of up to 5% in some flocks. In the United States, it is less common but has been reported in the western states. The disease affects primarily sheep, with a higher incidence in lambs and young adults (6 to 18 months of age), but all ages are susceptible. Goats are less commonly affected, but outbreaks have been reported, particularly in dairy goat herds. The morbidity rate in affected flocks can range from 1% to 10%, and mortality is high if untreated, approaching 100% in clinically affected animals. The economic impact includes direct losses from death, reduced weight gain, and condemnation of carcasses at slaughter. The prevalence is influenced by management practices, such as the presence of dogs on the farm, inadequate carcass disposal, and lack of routine deworming of dogs. Seasonal patterns are not pronounced, but cases may be more frequently diagnosed in late winter and spring when neurological signs become apparent after a long incubation period.

The pathophysiology of coenurosis involves the mechanical and inflammatory effects of the developing cyst within the CNS. After ingestion, the oncosphere migrates to the brain, often lodging in the cerebral hemispheres, particularly the frontal and parietal lobes, but can also occur in the cerebellum, brainstem, or spinal cord. The initial migration causes small hemorrhages and microglial reactions. As the cyst grows, it exerts pressure on surrounding brain tissue, leading to compression, ischemia, and necrosis. The cyst also induces a granulomatous inflammatory response, with infiltration of eosinophils, lymphocytes, and macrophages. The presence of the cyst disrupts normal cerebrospinal fluid (CSF) flow, potentially causing obstructive hydrocephalus. The clinical signs are directly related to the location and size of the cyst. Cysts in the cerebral cortex cause depression, head pressing, and circling; cerebellar cysts cause ataxia and incoordination; brainstem cysts may cause cranial nerve deficits. The progressive growth of the cyst leads to worsening neurological signs and eventually death due to respiratory failure or secondary complications such as aspiration pneumonia. The immune response of the host is generally ineffective in eliminating the cyst, and the parasite can evade the immune system by modulating the host's inflammatory response.

Several factors predispose sheep and goats to coenurosis. The most significant is the presence of infected definitive hosts (dogs) on the farm or in the vicinity. Dogs that are not regularly dewormed or that have access to raw sheep carcasses are a major risk factor. Poor biosecurity practices, such as improper disposal of dead stock (leaving carcasses in the field), allow dogs to scavenge and become infected. Overcrowding and high stocking density increase the likelihood of pasture contamination with dog feces. Young animals, particularly lambs and kids, are more susceptible due to their less developed immune system and exploratory behavior. The disease is more common in extensive grazing systems where dogs are used for herding. In some regions, the presence of wild canids (foxes, wolves) can serve as a reservoir. Additionally, environmental factors such as moist, cool climates favor the survival of tapeworm eggs on pasture. Breed susceptibility has not been clearly established, but some studies suggest that certain breeds may have a higher incidence, possibly due to management practices. Poor nutrition and concurrent diseases may increase susceptibility by compromising the immune system.

Clinical signs of coenurosis are variable and depend on the location and size of the cyst. The disease typically has a slow, progressive course over weeks to months. Early signs are often subtle and include mild depression, reduced appetite, and a tendency to lag behind the flock. As the cyst enlarges, neurological signs become more apparent. Common signs include head pressing, circling (usually toward the side of the lesion), ataxia, incoordination, and blindness. Animals may show a wide-based stance and may fall or stumble. In some cases, there is hyperesthesia and muscle tremors. If the cyst is in the cerebellum, signs include intention tremors, nystagmus, and a goose-stepping gait. Brainstem involvement can cause cranial nerve deficits, such as facial paralysis, drooping ear, and difficulty swallowing. Spinal cord cysts can cause paresis or paralysis of the hindlimbs. As the disease progresses, animals become recumbent, unable to rise, and may develop opisthotonos. Death occurs due to respiratory failure or secondary complications. In goats, the clinical course may be more acute, with rapid onset of severe neurological signs. The FAMACHA anemia score is typically normal (1-2) as coenurosis does not cause anemia. Body condition may deteriorate due to reduced feed intake.

Differential diagnoses for coenurosis include other causes of neurological disease in small ruminants. Key differentials are: 1) Listeriosis (Listeria monocytogenes) - causes encephalitis with unilateral facial nerve paralysis, circling, and fever; diagnosis by CSF analysis (mononuclear pleocytosis) and culture/PCR. 2) Polioencephalomalacia (PEM) - caused by thiamine deficiency or sulfur toxicity; presents with cortical blindness, head pressing, and opisthotonos; responds to thiamine administration. 3) Pregnancy toxemia (ketosis) - occurs in late gestation, especially with multiple fetuses; signs include depression, weakness, and neurological signs; diagnosis by elevated blood BHB (>1.6 mmol/L) and hypoglycemia. 4) Brain abscess (e.g., from Corynebacterium pseudotuberculosis) - may cause similar signs; diagnosis by imaging and culture. 5) Tetanus - caused by Clostridium tetani; presents with muscle rigidity, prolapsed nictitating membrane, and spastic paralysis; history of wound. 6) Rabies - a zoonotic disease with progressive neurological signs; diagnosis by history of exposure and laboratory testing. 7) Ovine progressive pneumonia (OPP) - a viral disease causing progressive weight loss and neurological signs in older sheep; diagnosis by serology. 8) Scrapie - a prion disease with progressive neurological signs, including pruritus and ataxia; diagnosis by histopathology of brain tissue. 9) Parasitic migration (e.g., Parelaphostrongylus tenuis) - can cause neurological signs in goats; diagnosis by CSF eosinophilia and history of exposure to deer. 10) Trauma - skull fracture or spinal injury; history of trauma and physical examination findings.

The diagnostic approach for coenurosis involves a stepwise process. 1) Flock history: Obtain a detailed history including age, breed, vaccination status, deworming program, presence of dogs, and recent changes in management. 2) Physical examination: Perform a thorough neurological examination, including assessment of mentation, cranial nerve function, gait, and postural reactions. Note any signs of head pressing, circling, or ataxia. 3) Differential diagnosis: Consider the list of differentials and rule out metabolic causes (pregnancy toxemia, PEM) with blood tests (BHB, glucose, thiamine response). 4) Blood tests: Collect blood for CBC, biochemistry, and BHB measurement. In coenurosis, these are usually within normal limits, but may show mild stress leukogram. 5) CSF analysis: Perform cerebrospinal fluid tap (atlanto-occipital or lumbosacral). In coenurosis, CSF may show mild mononuclear pleocytosis and elevated protein, but is often normal. 6) Imaging: If available, advanced imaging such as computed tomography (CT) or magnetic resonance imaging (MRI) can identify the cyst. However, these are rarely available in field settings. 7) Response to treatment: Administer thiamine and dexamethasone as a therapeutic trial; if no response, coenurosis is more likely. 8) Necropsy: If the animal dies or is euthanized, perform a necropsy and examine the brain for the presence of a cyst. This is the definitive diagnosis.

In coenurosis, routine laboratory findings are often unremarkable. Complete blood count (CBC) may show mild eosinophilia in some cases, but this is not consistent. Serum biochemistry is typically within normal limits, although there may be mild elevations in muscle enzymes (CK, AST) due to recumbency. Blood glucose and BHB levels are normal, helping to rule out pregnancy toxemia. CSF analysis may reveal a mild increase in protein concentration (30-50 mg/dL) and a mild mononuclear pleocytosis (10-50 cells/µL), but these findings are nonspecific. In some cases, CSF may be normal. Fecal examination is not useful for diagnosis, as the parasite does not shed eggs in the feces of sheep. Serological tests, such as ELISA for detection of antibodies against Taenia multiceps, have been developed but are not widely available and have variable sensitivity and specificity. Molecular techniques, such as PCR, can detect parasite DNA in CSF or tissue samples, but are primarily used in research settings. Definitive diagnosis is made by histopathological examination of the brain, which reveals the characteristic cyst with multiple protoscolices.

Imaging modalities can be helpful in the antemortem diagnosis of coenurosis. Ultrasonography is not useful for brain imaging due to the skull. Radiography is also of limited value. Computed tomography (CT) is the most sensitive imaging modality for detecting Coenurus cerebralis cysts. On CT, the cyst appears as a well-defined, hypodense, fluid-filled lesion with a thin, contrast-enhancing rim. The cyst is typically located in the cerebral hemisphere, and there may be associated mass effect, midline shift, and hydrocephalus. Magnetic resonance imaging (MRI) provides even better soft tissue contrast and can show the cyst contents and surrounding edema. However, these imaging modalities are rarely available in field practice and are typically used in referral centers. In the absence of advanced imaging, the diagnosis is often made based on clinical signs and response to treatment, with confirmation at necropsy.

Histopathological examination of the brain is the gold standard for diagnosis of coenurosis. Grossly, the cyst is a fluid-filled, thin-walled structure containing multiple white nodules (protoscolices) attached to the inner wall. The cyst is usually 2-5 cm in diameter and may be unilocular or multilocular. Microscopically, the cyst wall is composed of an outer cuticular layer and an inner germinal layer. The protoscolices have characteristic hooklets and suckers. Surrounding brain tissue shows compression, necrosis, gliosis, and infiltration of inflammatory cells, including eosinophils, lymphocytes, and macrophages. There may be evidence of perivascular cuffing and edema. In chronic cases, there may be fibrosis and calcification. Cytological examination of the cyst fluid may reveal protoscolices and hooklets, but this is rarely performed antemortem. CSF cytology may show a mild mononuclear pleocytosis, but is not diagnostic.

Treatment of coenurosis is primarily surgical, involving the removal of the cyst from the brain. This is only feasible if the cyst is accessible and the animal is a valuable breeding animal. The surgical procedure, known as craniotomy, is performed under general anesthesia. The cyst is located using imaging or by palpation through the skull, and a trephine is used to create a hole in the skull. The cyst is then aspirated and removed. Postoperative care includes antibiotics and anti-inflammatory drugs. However, surgery is often not practical in a flock setting due to cost and the need for specialized equipment. Medical treatment with anthelmintics, such as praziquantel or albendazole, has been attempted but is generally ineffective in killing the cyst and may cause an inflammatory reaction that worsens clinical signs. Corticosteroids, such as dexamethasone, may be used to reduce inflammation and cerebral edema, but provide only temporary relief. In most cases, affected animals are euthanized on humane grounds. Prevention is the most effective control strategy, involving regular deworming of dogs with praziquantel (5 mg/kg PO) or epsiprantel (5.5 mg/kg PO), preventing dogs from accessing sheep carcasses, and proper disposal of dead stock.

The prognosis for coenurosis is poor to grave. Without treatment, the disease is invariably fatal, with death occurring within weeks to months after the onset of clinical signs. Surgical removal of the cyst can be curative if the cyst is accessible and the surgery is successful, but the prognosis is guarded due to the risk of surgical complications and recurrence. The prognosis is worse in animals with severe neurological deficits, such as recumbency or blindness, and in those with cysts in the brainstem or spinal cord. Even after successful surgery, there may be residual neurological deficits. In a flock setting, the economic impact is significant, and affected animals are often culled. The prognosis for the flock is good if control measures are implemented to break the life cycle.

Follow-up for individual animals that undergo surgery includes monitoring for neurological improvement and complications. Postoperative care may include antibiotics (e.g., oxytetracycline 10 mg/kg IM q24h for 5 days) and anti-inflammatory drugs (e.g., flunixin meglumine 1.1 mg/kg IV q24h for 3 days). The animal should be housed in a clean, quiet environment and monitored for seizures or other neurological signs. For the flock, follow-up involves implementing a comprehensive control program. This includes regular deworming of all dogs on the farm with praziquantel (5 mg/kg PO) every 6-8 weeks, preventing dogs from accessing sheep carcasses, and ensuring proper disposal of dead stock (e.g., incineration or burial). Pasture management may include rotating pastures to reduce contamination. It is also important to educate farm workers about the disease and the importance of biosecurity. Regular monitoring of the flock for new cases is essential, and any suspected cases should be promptly investigated.

Clinical pearls: 1) Coenurosis should be considered in any young sheep or goat with progressive neurological signs, especially if there is a history of dogs on the farm. 2) The classic sign of head pressing and circling is often seen, but the absence of these signs does not rule out the disease. 3) A therapeutic trial with thiamine and dexamethasone can help differentiate coenurosis from PEM, as PEM responds to thiamine. 4) CSF analysis is often normal in coenurosis, so a normal CSF does not exclude the disease. 5) Necropsy is the most reliable way to confirm the diagnosis. Pitfalls: 1) Misdiagnosing coenurosis as pregnancy toxemia in late gestation ewes, leading to inappropriate treatment. 2) Failing to consider coenurosis in goats, as it is less common but can occur. 3) Attempting medical treatment with anthelmintics, which is ineffective and may cause an inflammatory reaction. 4) Overlooking the importance of dog deworming in the control program. 5) Not performing a thorough neurological examination, leading to missed diagnosis.

There is no effective medical treatment for coenurosis in sheep and goats. Anthelmintics such as praziquantel (5 mg/kg PO) and albendazole (10 mg/kg PO) have been used experimentally but are not recommended due to lack of efficacy and potential for adverse reactions. Surgical removal is the only curative treatment. For supportive care, the following protocols may be used: 1) Dexamethasone: 0.1-0.2 mg/kg IV or IM q24h for 3-5 days to reduce cerebral edema and inflammation. 2) Thiamine hydrochloride: 10 mg/kg IM or IV q12h for 3-5 days, if PEM is a differential. 3) Broad-spectrum antibiotics: Oxytetracycline (10 mg/kg IM q24h) or penicillin G procaine (20,000 IU/kg IM q24h) to prevent secondary infections, especially if surgery is performed. 4) Fluid therapy: If the animal is recumbent, administer IV fluids (e.g., lactated Ringer's solution) at maintenance rates (50-60 mL/kg/day). 5) Analgesics: Flunixin meglumine (1.1 mg/kg IV q24h) or meloxicam (0.5 mg/kg PO q24h) for pain management. Withdrawal times for meat and milk must be observed according to label directions. For prevention, deworming of dogs with praziquantel (5 mg/kg PO) every 6-8 weeks is highly effective.

Coenurosis is a well-documented disease in the veterinary literature. Key studies include: 1) A study by Edwards and Herbert (1982) in Wales reported a flock prevalence of 5% and highlighted the role of dogs in transmission. 2) A study by Soulsby (1982) in the UK described the life cycle and pathology of Taenia multiceps. 3) A study by Scala et al. (2007) in Italy reported an outbreak in goats, emphasizing the need for control measures. 4) A study by Achenef et al. (2012) in Ethiopia found a prevalence of 3.5% in sheep and identified risk factors such as the presence of dogs and poor carcass disposal. 5) A study by Christodoulopoulos et al. (2016) in Greece evaluated the use of CT for antemortem diagnosis and reported successful surgical removal of cysts. 6) A study by Varcasia et al. (2016) in Italy used molecular techniques to characterize the parasite and confirmed the zoonotic potential. Consensus guidelines from the American Association of Small Ruminant Practitioners (AASRP) and the European College of Small Ruminant Health Management (ECSRHM) recommend a comprehensive control program including regular deworming of dogs, proper carcass disposal, and biosecurity measures. There is no vaccine available for coenurosis in sheep or goats.